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ABSTRACT Osteomyelitis is a difficult-to-eradicate bone infection typically caused by Staphylococcus aureus. In this study, we
investigated the in vivo transcriptional adaptation of S. aureus during bone infection. To this end, we determined the transcrip-
tome of S. aureus during the acute (day 7) and chronic (day 28) phases of experimental murine osteomyelitis using RNA se-
quencing (RNA-Seq). We identified a total of 180 genes significantly more highly expressed by S. aureus during acute or chronic
in vivo infection than under in vitro growth conditions. These genes encoded proteins involved in gluconeogenesis, proteolysis
of host proteins, iron acquisition, evasion of host immune defenses, and stress responses. At the regulatory level, sarA and -R
and saeR and -S as well as the small RNA RsaC were predominantly expressed by S. aureus during in vivo infection. Only nine
genes, including the genes encoding the arginine deiminase (ADI) pathway and those involved in the stringent response, were
significantly more highly expressed by S. aureus during the chronic than the acute stage of infection. Analysis by quantitative
reverse transcription-PCR (qRT-PCR) of a subset of these in vivo-expressed genes in clinical specimens yielded the same results
as those observed in the murine system. Collectively, our results show that during acute osteomyelitis, S. aureus induced the
transcription of genes that mediate metabolic adaptation, immune evasion, and replication. During the chronic phase, however,
S. aureus switched its transcriptional response from a proliferative to a persistence mode, probably driven by the severe defi-
ciency in nutrient supplies. Interfering with the survival strategies of S. aureus during chronic infection could lead to more effec-
tive treatments.
IMPORTANCE The key to the survival success of pathogens during an infection is their capacity to rapidly adjust to the host envi-
ronment and to evade the host defenses. Understanding how a pathogen redirects and fine-tunes its gene expression in response
to the challenges of infection is central to the development of more efficient anti-infective therapies. Osteomyelitis is a debilitat-
ing infection of the bone predominantly caused by S. aureus. In this study, we evaluated the transcriptional response of S. au-
reus during bone infection. Our results indicate that S. aureus reprograms its genetic repertoire during the acute phase of infec-
tion to adapt to nutrient availability and to replicate within the host. During the chronic phase, S. aureus upregulates a survival
genetic program activated in response to nutrient starvation. Thus, we have uncovered key survival pathways of S. aureus during
acute and chronic osteomyelitis that can be used as therapeutic targets.
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Staphylococcus aureus is a major human pathogen and an im-portant cause of death and morbidity worldwide. Of major
concern are the continuous emergence and spread of antibiotic-
resistant strains, such as methicillin-resistant S. aureus (MRSA),
which have limited treatment options (1). Although S. aureus is
part of the normal human microbiota as a commensal microor-
ganism, it can also be the cause of a wide range of diseases if given
the chance to access deeper tissues. S. aureus can establish infec-
tions in a range of different organs, including the lungs, kidneys,
and heart, as well as in diverse host tissues, such as the skin, bones,
and blood (2). The ability of S. aureus to cope with the biological
pressure imposed by the immune response as well as by the short-
age of nutrients within the different host microenvironments is
central to its success as a pathogen. The rapid adaptation of S. au-
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reus to changing environments is accompanied by reprogram-
ming complex regulatory networks to activate the expression of
genes essential for its survival in the new environment while re-
pressing those that are unnecessary or potentially deleterious. Dis-
secting the transcriptional adaptation of S. aureus during in vivo
infection is therefore central for understanding how this pathogen
interacts with the host and causes disease.
The transcriptional adaptation of S. aureus during in vivo in-
fection is relatively unexplored. Examination of S. aureus tran-
scriptional response in a rabbit subcutaneous cage model (3), in a
mouse model of S. aureus pneumonia (4), in human cutaneous
abscesses (5), and in murine kidneys (5) using microarray tech-
nology has demonstrated that genes regulated in vivo differ greatly
from those regulated in vitro. This underscores the need for in vivo
model systems that mimic, as closely as possible, the pathophysi-
ology of the human infection for understanding the transcrip-
tional adaptation of S. aureus to the host during productive infec-
tion. We recently established a model of metastatic osteomyelitis
initiated after intravenous inoculation of S. aureus whose patho-
logical features closely resemble those of acute and chronic human
disease (6). Osteomyelitis is an infection of the bone predomi-
nantly caused by S. aureus that can be associatedwith high levels of
inflammation and bone tissue destruction (7). Despite long and
high-dose treatment, the rate of clinical failure in osteomyelitis
treatment is very high, and these infections frequently result in
loss of function and extremity amputation (8). Ourmurinemodel
of staphylococcal osteomyelitis represents a robust platform to
investigate how S. aureus coordinates its gene expression during
the acute and chronic phases of bone infection. This information
could be used to develop novel anti-infective approaches aimed at
interfering with S. aureus within-host adaptation, thereby en-
abling the immune system to eliminate the pathogen in a more
natural way.
Most current research regarding staphylococcal pathogenesis
has focused on the identification, functional properties, and reg-
ulation of individual virulence determinants. However, beyond
the induction of genes encoding virulence determinants, the
whole-genome expression profile of in vivo-infecting bacteria will
comprise other genes that are likely to be essential for in vivo
survival. The products encoded by these genesmay not be harmful
to the host but may help the microbe to subvert the host defenses,
and thus they are not specifically ascribed a role as virulence de-
terminants. Instead, these genes are likely to encode functions
required for growth in vivo, although they may be dispensable for
the bacterial growth under in vitro conditions. In the study pre-
sented here, we analyzed the genome-wide transcriptional expres-
sion of S. aureus isolated from the bones of experimentally in-
fected mice during the acute and chronic phases of infection by
deep RNA sequencing (RNA-Seq) using Illumina technology. The
results in the murine model were validated in clinical specimens.
The results of our study provide the first high-resolutionmapping
of the integral adaptive transcriptional response of S. aureus to the
host during acute and chronic bone infection.
RESULTS
RNA-Seq analysis of S. aureus transcriptional adaptation dur-
ing acute and chronic experimental osteomyelitis. We used a
previously described murine model of bone infection to deter-
mine the transcriptional profile of S. aureus during acute (AC;
7 days of infection) and chronic (CH; 28 days of infection) exper-
imental osteomyelitis (6). In thismodel, S. aureus grown in vitro to
exponential phase was injected intravenously into C57BL/6 mice
and entered the bones through the bloodstream (6). Following an
acute phase of progressive growth, the bacterial loads in the bones
declined, and a surviving population remained relatively stable
during the chronic phase of infection (6). Bacterial RNA was ex-
tracted from the bones of 8 to 10mice at days 7 (AC) and 28 (CH)
of infection. Integratedmaps of genes and their level of expression
in S. aureus during in vitro exponential (EX) growth in complex
medium and AC and CH in vivo bone infection were then gener-
ated using Illumina deep-sequencing technology. Three indepen-
dent biological replicates were performed for each set of samples.
Sequence readswere subjected to a sequential filtering process and
aligned to the reference genome of S. aureus strain 6850 (9). Al-
though each of the samples produced between 53 and 105 million
reads, the numbers of final bacterial mRNA reads differed consid-
erably between conditions (see Table S1 in the supplemental ma-
terial). The initial data matrix comprises count data across 2,503
genes, covering more than 95% of the S. aureus 6850 genome (9).
The distribution of raw read counts following the rank ordering of
genes from scantily to highly abundant revealed a distribution
where most genes had counts of between 100 and 10,000 for the
EX andAC conditions (see Fig. S1A in the supplementalmaterial).
However, in the case of CH data sets, a high number of genes were
scantily covered or completely lacked coverage (see Fig. S1A in the
supplemental material). Since the initial numbers of reads before
removal of those originating from the host were similar between
the different conditions (see Table S1 in the supplemental mate-
rial), the poor coverage of CH samples could be attributed to the
moderately lower bacterial numbers observed during this phase of
infection (6) and/or to a much lower physiological activity of
S. aureus during this phase of infection. To normalize each repli-
cate within each condition against gene length and differing li-
brary sizes, the commonly used RPKM (reads per kilobase per
million of mapped reads) method was applied. However, we ob-
served that while the distribution of the RPKMdata gave a picture
comparable to that of the raw data for EX and AC conditions, the
values for the scantily abundant genes of the CH condition were
severely overinflated after RPKM normalization (see Fig. S1B in
the supplemental material). These overinflated gene expression
values can have a discordantly confounding effect on the down-
stream interpretation of differential gene expression. To over-
come this problem, all replicates for each condition were random
resampled to equal the smallest library size of 26,251 reads, which
produced comparable distributions for further analysis (see
Fig. S1C and Table S2 in the supplemental material).
Global gene expression analysis of S. aureus under in vitro
growth and in vivo infection. Clustering and ordination were
used to determine the similarity among the biological replicates
within each condition as well as the similarities between the tran-
scriptional profiles of S. aureusunder the different conditions. The
dendrogram depicted in Fig. 1A revealed that all replicates within
each condition grouped together, underlining the high reproduc-
ibility of the method. Permutational multivariate analysis of vari-
ance (PERMANOVA) showed that the clusterings of gene expres-
sion data for the three conditions were indeed significantly
different from one another (P 0.05) (see Table S3 in the supple-
mental material). The ordination plot generated by principal co-
ordinate analysis (PCoA),which orders samples according to their
global similarity based on expression data, shows that the global
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patterns of the transcriptomes were highly different between in
vitro (EX) and in vivo (AC andCH) conditions, as indicated by the
first principal component (PCO1) axis, which explains 73.9% of
the total variation (Fig. 1B). The second principal component
(PCO2) axis, which explains the variation between the in vivo
transcriptomes (AC versus CH), covered only 12.3% of the total
variation (Fig. 1B). This was further confirmed by performing
pairwise comparison of AC versus EX (Fig. 1C) and AC versus CH
(Fig. 1D) transcriptomes, which indicated that differences in gene
expression were more extensive between S. aureus grown in vitro
(EX) and in vivoAC (Fig. 1C) than between the in vivoAC andCH
conditions (Fig. 1D). A circular ideogramplotting themean abun-
dance of transcripts at the genomic position of S. aureus strain
6850 is shown in Fig. S2 in the supplemental material.
Functional categorization of transcripts expressed by S. au-
reus during in vitro growth and in vivo infection. Gene expres-
sion analysis based on the relative abundances of gene transcripts
assigned to their respective clusters of orthologous groups (COG)
showed that a large amount of sequence reads could be assigned to
the COG class “Metabolism,” followed by “Information, storage
and processing” in in vitro EX growth and “Cellular processes and
signaling” in AC and CH phases in vivo (Fig. 2A). The pattern and
distribution of transcripts among the COG categories are shown
in Fig. 2B. While genes assigned to the category “Translation, ri-
bosomal structure and biogenesis” weremore highly expressed by
S. aureusduring in vitroEXgrowth, a higher number of transcripts
encoding proteins classfied in “Post-translational modification,
protein turnover, and chaperones” were detected in S. aureus dur-
ingAC andCH infection. Regarding the categories associatedwith
“Metabolism,” transcripts related to the category “Energy produc-
tion and conversion” were considerably more abundant in S. au-
reus during in vitro EX growth, while transcripts related to the
cateogry “Amino acid transport and metabolism” and “Inorganic
transport andmetabolism” were more abundant in S. aureus dur-
ing AC and CH infection (Fig. 2B).
Differential gene expression by S. aureus between in vitro
and in vivo conditions. Differential gene expression between
pairs of conditions analyzed using a suite of algorithms (DESeq,
EdgeR, and SAMseq) revealed that a total of 444 genes were dif-
ferentially expressed by S. aureus between AC infection and in
vitro EX growth; 180 genes were significantly more highly ex-
pressed during AC infection, and 264 genes were significantly
more highly expressed during EX growth (Table 1). In contrast,
only 51 genes were differentially expressed by S. aureus between in
vivoCH and AC infection; specifically, 42 genes were expressed to
higher levels during AC infection and only 9 genes during CH
infection (Table 1). The complete list of the differentially ex-
pressed genes is provided in Table S4 in the supplemental mate-
rial.
(i) Differential expression of genes involved in metabolism.
The capacity of S. aureus to adapt itsmetabolism to the diverse and
fluctuating environments is a prerequisite for survival during in
vivo infection. We observed a number of transcripts encoding en-
zymes involved in the glycolytic pathway (glkA, pgi, and pfkA)
expressed to a higher level in S. aureus during in vitro EX growth,
suggesting that glucose is the major carbon source in this growth
condition (Fig. 3A). The number of transcripts encoding glyco-
lytic enzymes was significantly reduced in S. aureus isolated from
infected bones and coincided with a large increase in transcripts
encoding enzymes involved in the gluconeogenesis pathway (fbp,
FIG1 Hierarchical clustering dendrogram (A) and two-dimensional PCoAplot (B) of the transcriptional data from S. aureusunder EX, AC, andCHconditions.
Bray-Curtis similarity scores were used to compare the different transcriptomes. Each shape represents one condition and each symbol one independent
experimental set. (C) Pairwise scatter plots for the S. aureus transcripts during EX growth versus AC infection. Each symbol represents the mean of triplicate
values. (D) Pairwise scatter plots for the S. aureus transcripts of AC versus CH infection. Each symbol represents the mean of triplicate values. The Pearson
correlation coefficient (r) is indicated in each plot analysis.
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fda, gapA, pyc, and pckA) (Fig. 3A). During in vitro EX growth in a
microaerobic environment, pyruvate originating from the glyco-
lytic pathway was obviously reduced to lactic acid, as revealed by a
high level of L-lactate dehydrogenase-encoding transcripts (ldh1)
(Fig. 3A), indicating overflow metabolism as previously observed
in aerobically growing S. aureus in an excess of glucose such as in
rich medium (10). Interestingly, we found that many genes en-
coding secreted proteolytic enzymes, including a metalloprotease
(aureolysin, encoded by aur), the serine protease V8 (sspA), two
cysteine proteases (staphopain A [scpA] and staphopain B [sspB]),
and five serine-like proteases (splABCEF), were largely expressed
by S. aureus during AC and CH infection (Fig. 3B). It is possible
that the primary role of these proteases is to break down host
proteins to provide the bacterium with nutrients in the form of
small peptides or amino acids.
Under aerobic conditions, a large proportion of the ATP in
microorganisms is synthetized by membrane-bound complexes
through oxidative phosphorylation. ATP synthesis fromADP and
Pi is catalyzed by the ATP synthase complex (FoF1 ATPase) and is
driven by the proton gradient generated by respiration. This path-
way was used by S. aureus only during in vitro growth, since the
transcripts of important components of this complex (atpA, -B,
-C, -D, -E, -F, and -G) were much more abundant in S. aureus
during in vitro EX growth than during AC and CH infection (see
Table S4 in the supplemental material). In the anaerobic environ-
ment encountered in the bones, S. aureus needs an alternative
FIG 2 COG category overview of S. aureus gene expression. Mean total percentage abundances of transcripts assigned to major COG classes (A) and COG
categories (B) during in vitro EX growth and during in vivo AC and CH infection are shown. The total abundance of transcripts of genes assigned to the genome
of S. aureus strain 6850 is included as a reference (gray area in panel B).
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pathway to generate energy. In this regard, arginine may serve as
an alternative energy source for S. aureus under anaerobic condi-
tions through its metabolism via the arginine deiminase (ADI)
pathway, encoded by the arc operon (11). The ADI pathway en-
compasses three reactions catalyzed by arginine deiminase (arcA,
also called adi in S. aureus strain 6850), ornithine carbamoyl trans-
ferase (arcB), and carbamate kinase (arcC), resulting in the con-
version of arginine into ornithine, ammonia, and CO2, with the
concomitant production of ATP. The transcriptional data indi-
cate that this pathway, including an arginine/ornithine antiporter
(arcD), and a transcriptional regulator (arcR), was predominantly
induced by S. aureus during CH infection (Fig. 3C).
(ii) Differential expression of genes involved in response to
stress. Survival of S. aureus in the host is dependent on evasion of
the host immune defense, including mechanisms of microbial
killing by phagocytes. These killing mechanisms involve the pro-
duction of reactive oxygen species (superoxide anions, hydrogen
peroxide, and hydroxyl radicals) and nitric oxide. Protection of
S. aureus against such oxidative stress is mediated mainly by the
PerR regulon, which comprises catalase (katA), alkylhydroperox-
ide reductase (ahpCF), the general stress protein Dps (dps), and
thioredoxin reductase (trxB) (12). These detoxifying proteins, in
addition to superoxide dismutase (sodA), were expressed by S. au-
reus to a much higher level during AC and CH infection than
during in vitro EX growth (Fig. 3D).
Proteins that have beenmodified by reactive oxygen and nitro-
gen species generated during infection are generally removed by
the proteasome system in order to preventmetabolic disturbances
(13). However, under severe oxidative conditions, such as those
encountered by S. aureus in infected tissue, proteins tend to un-
fold and aggregate due to the exposure of patches of hydrophobic
amino acids, thus becoming less susceptible to proteolytic cleav-
age (13). Hsp100/Clp ATPases constitute a family of closely re-
lated proteins that catalyze the unfolding, disassembly, and disag-
gregation of oxidized proteins. Clp ATPases are important
components of the stress response in S. aureus (14). The transcrip-
tome data revealed that the level of expression of the three genes
(clpC, clpL, and clpB) encoding Clp ATPases was significantly
higher in S. aureus during AC and CH infection than during in
vitro EX growth (Fig. 3D). In Escherichia coli, ClpB cooperates
with the DnaK chaperone system to solubilize larger protein ag-
gregates (15). Likewise, we found that dnaK transcripts were sig-
nificantly more abundant in S. aureus growing in infected tissue
(AC and CH) than in culture medium (EX) (Fig. 3D).
When microorganisms face environments with nutrient limi-
tation and amino acid starvation, such as those encountered dur-
ing in vivo infection, a coordinated program known as the strin-
gent response is induced (16). Amino acid starvation results in the
activation of the ribosome-associated enzyme RelA, which is the
major synthetase of the small-molecule effectors guanosine tetra-
and pentaphosphates [(p)ppGpp] (16). (p)ppGpp levels are also
controlled by the spoT gene product, a bifunctional enzyme hav-
ing both a regulated hydrolase activity for degrading (p)ppGpp
and a weak synthetase activity (16). Binding of (p)ppGpp to RNA
polymerase modulates the transcription of hundreds of genes and
remodels the bacterial physiology (16). We found that the genes
encoding RelA/SpoT were significantly expressed only during CH
infection (Fig. 3D), further confirming the severe nutrient limita-
tion faced by S. aureus in chronically infected tissue.
(iii) Differential expression of genes required for tissue col-
onization and subversion of the host defense. The initial step of
S. aureus infection is to attach to the host tissue. For this purpose,
S. aureus strains express surface receptors designated
MSCRAMMs (microbial surface components recognizing adhe-
sive matrix molecules) that interact with proteins of the extracel-
lular matrix (17). Binding to fibronectin, elastin, and fibrinogen
seems to be the major mechanism of S. aureus for infection of
bone tissue, since the transcripts of genes for fibronectin-binding
protein A (fnbA), elastin-binding protein (ebpS), and fibrinogen-
binding clumping factor A (clfA) were highly abundant in S. au-
reus during AC and CH infection (Fig. 4). The gene encoding the
extracellular adherence protein Map (also known as Eap), which
has been shown to bind to cartilage (18), was significantly ex-
pressed by S. aureus during the AC phase of infection (Fig. 4).
To survive inside the host and maintain a persistent infection,
S. aureus uses a variety of mechanisms to evade or overcome the
host immune defenses, especially the innate immune system (19).
The staphylococcal complement inhibitor (SCIN), which inter-
feres with all complement activation pathways (the lectin, classi-
cal, and alternative pathways) by blocking C3 convertases, is the
most efficient complement inhibitor (20).We found that the gene
encoding SCIN (scn) was significantly more highly expressed by
S. aureus during AC and CH infection than during in vitro EX
growth (Fig. 4).
S. aureus secretes numerous exotoxins that directly destroy
phagocytic cells, representing a very efficient way to evade
phagocytic-mediated killing (21). These exotoxins include pore-
forming toxins such as -hemolysin and the bi-component
-hemolysin (HlgACB), LukGH (also known as LukAB) and
LukED, -hemolysin, and the phenol-soluble modulins (PSMs)
(21). The gene encoding the single-component-hemolysin (hla)
was highly expressed by S. aureus during AC and CH infection
TABLE 1 Number of genes differentially expressed by S. aureus between in vitro EX growth and in vivo AC infection and between in vivo AC and
CH infection
Conditions testeda Total no. of differentially expressed genesb No. of genes





AC/EX 388 (388ER/208SS) 559 (388DS/264SS) 280 (208DS/264ER) 444 180/264
CH/AC 22 (22ER/13SS) 114 (22DS/42SS) 52 (13DS/42ER) 51 9/42
a AC, in vivo acute bone infection (7 days); EX, in vitro growth to exponential phase; CH, in vivo chronic bone infection (28 days).
b Gene expression was determined to be significant using the parametric algorithms DESeq (DS) and EdgeR (ER) (P 0.05) and the nonparametric algorithm SAMSeq (SS) (q
0.05). P values have been adjusted to take into account for multiple testing. The total numbers of genes identified as being differentially expressed by 2 or more of the methods and
the number of genes significantly induced in each of the conditions are given. Results in parentheses are numbers of common significantly differentially expressed genes, with the
corresponding algorithms.
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(Fig. 4). The genes encoding LukGH (lukG and -H) and LukED
(lukE and -D) were also expressed to a greater extent by S. aureus
during in vivo infection but predominately during the CH phase
(Fig. 4). PSMs are small peptide toxins known to activate, attract,
and lyse neutrophils (22) as well as to mediate S. aureus phago-
somal escape in both professional and nonprofessional phago-
cytes (23). Depending on the size, PSMs are classified into two
groups. The smaller -type PSMs (PSM1, PSM2, PSM3, and
PSM4), with a length of 20 to 30 amino acids, are considered the
most toxic PSMs, whereas the larger -type PSMs (PSM1 and
PSM2), approximately 44 amino acids in length, seem to have
different functions (22). Interestingly, the genes psmA1, -2, and -3,
encoding PSM1 to -3, were highly expressed by S. aureus during
AC and CH infection, although to a much greater extent during
the latter. On the other hand, the genes encoding PSM1 (psmB1)
and PSM2 (psmB2) were expressed by the bacteria only during in
vitro EX growth (Fig. 4), indicating that PSM may not be re-
quired by S. aureus to survive within the bone tissue.
FIG 3 Expression of genes related to glycolysis/gluconeogenesis, proteases, ADI, and stress responses by S. aureus under in vitro and in vivo conditions.
Expression of genes encoding proteins involved in glycolysis/gluconeogenesis (A), those with protease activity (B), those involved in the ADI pathway (C), and
those involved in the stress response (D) by S. aureus during EX, AC, and CH growth is shown. Each bar represents the mean and standard deviation (SD) of
triplicates. n.s, the differences between AC and EX mean values and between CH and AC mean values are not statistically significant.
Szafranska et al.
















(iv)Differential expression of genes involved in iron homeo-
stasis. Iron uptake is a critical event for S. aureus survival within
the host, as the host limits iron availability as part of its innate
defense against invading pathogens (24). The gene encoding fer-
ritin (ftn), which is responsible for mobilizing iron from intracel-
lular reserves when external iron supplies are limited (25), was
highly expressed by S. aureus during the AC phase and at lower
levels during the CH phase of infection (see Table S4 in the sup-
plemental material). S. aureus has evolved several sophisticated
iron uptake systems, including the cell wall-based iron acquisition
Isd pathway (26).Within this pathway, the genes encoding the cell
wall-anchored heme-binding protein IsdA and the hemoglobin-
binding protein IsdBweremore extensively expressed by S. aureus
during the CH phase of infection (see Table S4 in the supplemen-
tal material).
(v) Differential expression of genes encoding two-
component regulatory systems (TCS). Two-component regula-
tory systems enable bacteria to sense their environment and re-
spond appropriately by coordinating gene expression. The
expression of most S. aureus virulence factors is directly or indi-
rectly controlled by diverse regulators, such as agr, sarA, and sae
(27). The transcription data showed high expression of agrA, -B,
and -C by S. aureus during in vitro EX growth and low expression
during AC and CH infection (see Table S5 in the supplemental
material). In contrast, the accessory regulators sarA and -R and
saeR and -S were expressed by S. aureus to a greater level in in-
fected bones (see Table S5 in the supplemental material). The
VicR/VicK (also known as WalK/WalR and YycG/YycF) regula-
tory systemwas alsomore highly expressed by S. aureus duringAC
and CH infection (see Table S5 in the supplemental material).
Expression of regulatory small RNAs by S. aureus during in
vitro growth and in vivo infection. In addition to the classical
transcriptional regulatory systems, noncoding small regulatory
RNAs (sRNAs) seem to play important roles in the posttranscrip-
tional regulation of many genes in S. aureus (28). The 15 most
highly expressed sRNAs of the well-known and characterized sR-
NAs in the Repository of Bacterial Small Regulatory RNA (BSRD)
database are shown in Table S6 in the supplemental material. The
sRNAs more highly induced by S. aureus under all conditions
tested were sRNAs with housekeeping functions, including the
4.5s RNA or ffs (ssao445.1) component of the signal recognition
particle (SRP), the RNase P (ssao1419.1) responsible for process-
ing of tRNAs, and the transfer-messenger RNA SsrA (ssao789.1),
which rescues stalled ribosomes during translation of defective
mRNAs. Among the 15 sRNAsmost highly expressed by S. aureus
during infection was RsaC (ssao624.1), which was expressed dur-
ing the AC phase (see Table S6 in the supplemental material). The
sRNAs corresponding to the T-box riboswitch (ssao357.2) in-
volved in the regulation ofmetB, encoding cystathionine gamma-
synthase, and that (ssao1688.1) involved in the regulation of thrS,
encoding threonyl-tRNA synthetase, were highly expressed by
S. aureus during both AC andCHphases of infection (see Table S6
in the supplemental material). The S-box riboswitch senses
S-adenosylmethionine and regulates methionine metabolism in
response to methionine starvation (29). The S-box (ssao1819.1)
leader ofmetK, encoding S-adenosylmethionine synthase, and the
S-box (ssao813.1) leader ofmetN2, encoding amethionine import
ATP-binding protein, were among the 15 sRNAs most highly ex-
pressed by S. aureus during CH infection (see Table S6 in the
supplemental material). This is in accordance with the assump-
FIG 4 Expression of genes encoding virulence factors by S. aureus under in
vitro and in vivo conditions. Expression of genes encoding proteins involved in
pathogenesis by S. aureus during EX, AC, and CH growth is shown. Each bar
represents the mean and SD of triplicates. n.s, the differences between AC and
EX mean values and between CH and AC mean values are not statistically
significant.
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tion of nutrients starvation during the CH phase of bone infec-
tion.
Expression of hypothetical proteins by S. aureus during in
vitro growth and in vivo infection.Many genes encodingproteins
with unknown function were expressed to a higher level by S. au-
reus during AC and CH infection than during in vitro EX growth
(see Table S4 in the supplemental material). These genes are of
particular interest because they are likely to be important for bac-
terial survival during the specific stages of osteomyelitis but no
obvious function has yet been assigned.
Confirmation of selected S. aureus in vivo-expressed genes
in human patients. The expression of key genes from different
functional categories found to be highly expressed by S. aureus
during in vivo infection in the experimental murine model was
then confirmed by qRT-PCR in infected bone samples isolated
from human patients. To this end, we collected clinical specimens
from patients with subacute or chronic S. aureus infection involv-
ing soft tissue and bones and used these samples to perform qRT-
PCR analysis of specific genes after direct extraction of RNA (see
Table S7 in the supplemental material). Similar to what was ob-
served in the murine osteomyelitis model, the S. aureus genes en-
coding the cysteine protease staphopain B (Fig. 5A), clumping
factor A (Fig. 5C), DnaK chaperon (Fig. 5D), arginine deiminase
(Fig. 5E), carbamate kinase (Fig. 5F), and amanganese ABC trans-
porter (Fig. 5G) were more highly expressed by S. aureus in the
infected human tissue than in S. aureus cultured in vitro in rich
medium. Also comparable to the murine system was the behavior
of the gene encoding the L-lactate dehydrogenase, whose expres-
sion was lower in S. aureus during in vivo bone infection (Fig. 5B).
We also assessed the global resemblance between the changes in
gene expression of S. aureus in the different human samples and
those of S. aureus isolated frommurine bones during AC and CH
infection using the Bray-Curtis similarity index. The dendrogram
of the Bray-Curtis distance matrix (Fig. 5H) revealed that the ex-
pression of the selected genes by S. aureus in patients 2 (P-2) and 3
(P-3) cluster very closely with the expression of those genes by
S. aureus isolated from chronic murine osteomyelitis (~80% sim-
ilarity). The respective S. aureus strains isolated from P-2 and P-3
were of the same spa type (t009) and therefore genetically closely
related (see Table S7 in the supplemental material). The gene ex-
pression pattern of S. aureus in patients 4 (P-4) and 5 (P-5) exhib-
ited around 60% similarity with the expression of genes by S. au-
reus in both AC and CH murine infection, whereas the gene
expression of patient 1 (P-1) was the most divergent (only 40%
similarity with the other data sets) (Fig. 5H). Interestingly, the
S. aureus strain infecting P-1 was an MRSA strain, whereas the
other strains were all methicillin-susceptible S. aureus (MSSA)
strains (see Table S7 in the supplemental material).
DISCUSSION
In this study, we characterized on a genome-wide scale the gene
expression profile of S. aureus during the acute (7 days) and
chronic (28 days) phases of hematogenous osteomyelitis in an
experimental murinemodel that closely mimics the natural infec-
tion in humans (6). As the ultimate aim is to bring these findings
closer to clinics, we confirmed the expression of a selected set of
S. aureus in vivo-expressed genes in the murine system in clinical
specimens from five patients with chronic staphylococcal osteo-
myelitis. Our results show that the variation in gene expression
was more extensive when we compared S. aureus grown in vitro
versus S. aureus in infected tissue in vivo than when we compared
S. aureus in vivo during AC versus CH phases of infection. These
observations suggest that S. aureus required a higher number of
genes for adjusting to the host environment than for longstanding
persistence within the infected tissue.
Acquisition of nutrients and metabolism within the host is a
fundamental aspect of S. aureus pathogenesis. The shift from gly-
colysis to gluconeogenesis observed in S. aureus transcriptional
response during the transition from the in vitro to the in vivo
environment indicates a lack of glucose availability in bone tissue.
The lack of easy-to-degrade nutrients during bone infection forces
the use of alternative carbon sources. In this regard, S. aureus has
evolved unique mechanisms to maximize the harvesting of nutri-
ents from host resources. Thus, we found that a number of genes
encoding secreted proteolytic enzymes (aur, sspA, sspB, scpA, and
splABCEF) were expressed by S. aureus only during infection. The
gene sspB, selected as representative of this group of proteolytic
enzymes, was also highly expressed by S. aureus in infected human
tissue. Similar to our results, the genes encoding proteases were
reported to be highly expressed by S. aureus strain USA300 in vivo
in a murinemodel of kidney infection (5). It is possible that S. au-
reus releases these proteases to obtain small peptides from the host
milieu. However, these enzymes have also been shown to play a
role in pathogenesis by inducing tissue destruction to facilitate
bacterial dissemination (30). The metabolic adjustment of S. au-
reus to the bone environment contrasts with that reported in the
lungs, where its growth was primarily driven by carbohydrates, as
indicated by the upregulation of glycolysis and the downregula-
tion of pathways for gluconeogenesis and amino acid catabolism
(4). These observations underscore the difference in nutrient
availability in the different anatomical locations within the host
and thus the bacterial need for multiple adaptive strategies for
survival during in vivo infection.
The transcriptomic profile also indicated that the aerobic elec-
tron transfer chain seems to be repressed in S. aureus during bone
infection. This is a critical issue, since the respiratory ATP synthe-
sis pathway has been proposed as a potential antibiotic target
against S. aureus and small-molecule inhibitors with diarylquino-
line scaffold have been shown to inhibit the growth of S. aureus in
the planktonic state as well as in metabolically resting bacteria
grown in a biofilm culture (31). However, the fact that this path-
way is not used by S. aureus during bone infectionmay hinder the
antimicrobial effect of these inhibitors for the treatment of S. au-
reus osteomyelitis. Interestingly, the ADI pathway, encoded by the
arc operon, was induced by S. aureus predominantly during the
CH phase of experimental bone infection and was highly ex-
pressed by S. aureus in all human samples. This pathway enables
S. aureus to use arginine as a source of energy under anaerobic
conditions and is generally induced when other sources of energy
such as glucose are absent (11). In addition to its role in generating
ATP under anaerobic conditions, the ADI pathway can also play a
role in maintaining pH homeostasis during infection, since the
ammonia generated during this process can neutralize acids gen-
erated by the fermentative metabolism (32). Because L-arginine
may also serve as a substrate for the production of antimicrobial
nitric oxide (NO) by the nitric oxide synthase in classically acti-
vated macrophages (M1) (33), the use of the ADI pathway may
help S. aureus to evade this antimicrobial mechanism by consum-
ing arginine, as shown for other pathogens (34).
Iron acquisition is fundamental for S. aureus to survive within
Szafranska et al.
















FIG 5 Confirmation of selected S. aureus in vivo-expressed genes in clinical samples by qRT-PCR. Changes (fold) in expression of sspB (A), ldh1 (B), clfA (C),
dnaK (D), adi (E), arcC (F), and the gene encoding the manganese ABC transporter (RSAU_000587) (G) in S. aureus in infected human tissue (circles) were
determined by qRT-PCR, and those in murine bones (squares) were determined by RNA-Seq. The expression of the respective gene by S. aureus grown in vitro
in rich medium was used as a reference to calculate the changes. Each circle represents one individual patient, and each square represents one independent
experimental set in the murine system, with black squares representing AC infection and white squares CH infection. (H) Hierarchical clustering dendrogram
showing the change (fold) in gene expression data determined by Bray-Curtis similarity scores. P-1 to P-5, individual patients; AC-1 to AC-3, individual data sets
from murine AC bone infection; CH-1 to CH-3, individual data sets from murine CH bone infection.
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the host (26). The in vivo transcriptional profile suggests that
S. aureus may use iron from its internal stores during AC osteo-
myelitis and may scavenge iron from the host by acquiring heme
complexes during CH osteomyelitis.
The transition from acute to chronic infection seems to be
associated with the induction of the stringent response, since the
RelA/SpoT system was significantly expressed by S. aureus only
during CH infection. The stringent response is a bacterial adapta-
tion to starvation and is essential for S. aureus viability (35). The
isolation of an S. aureus strain harboring a mutation in relA from
a patient with a very difficult-to-treat chronic infection supports
the relevance of the stringent response for S. aureus in vivo persis-
tence (36).
Important sets of genes expressed by S. aureus during in vivo
infection were those aiming to interfere with the immune defense
of the host. In this regard, we found a high level of expression of
genes encoding proteins (e.g., SCIN) that interfere with the com-
plement system and thus hamper bacterial phagocytic uptake.
Also, genes encoding toxins that can kill host immune cells, such
as -hemolysin, -hemolysin (HlgAB and HlgCB), and leukocid-
ins LukED and LukAB, as well as genes encoding PSMs, were
highly expressed by S. aureus during bone infection. In this regard,
LukED was recently reported to contribute to the lethality ob-
served upon S. aureus bloodstream infection (37), and
-hemolysin has been implicated in the pathogenesis of lethal
pneumoniae (38), severe skin infections (39), and brain abscesses
(40).
The vast array of S. aureus virulence determinants are very
tightly controlled by several regulators, which include the two-
component regulatory systems agrAC and saeRS aswell as the sarA
gene family. Investigation of the regulatory networks coordinat-
ing the expression of S. aureus virulence factors has essentially
been limited to in vitro culture conditions because of the difficulty
of monitoring the activity of regulatory networks in the infected
host. This is complicated further by the fact that one target gene
can be under the control of several regulators to ensure that spe-
cific factors are produced only when required during the infection
process. The regulatory networks expressed by S. aureus during in
vivo infection remain largely unclear. In this study, we found that
agrwas highly expressed by S. aureusduring in vitroEXgrowth but
at significantly reduced levels during bone infection. Interestingly,
agr-defective mutants have been shown to be selected in patients
with chronic infections (41). In contrast, the loci encoding the
saeRS system were expressed at very low levels by S. aureus during
in vitro EX growth andwere significantly upregulated during bone
infection, mainly during the AC phase of infection. In line with
this observation,Date et al. (5) reported agrC to be downregulated
and saeR upregulated by S. aureus USA300 in the kidneys of in-
fected mice. The higher expression of the sarA locus may be re-
sponsible for the high expression level of genes encoding
fibronectin- and fibrinogen-binding proteins as well as those en-
coding -, -, and -toxins observed here during AC and CH
infection in vivo (42). The VicR/VicK (also known asWalK/WalR
andYycG/YycF) regulatory systemwas alsomore highly expressed
by S. aureus during AC and CH infection. This two-component
system regulates expression of genes encoding proteins involved
in modulating the cell wall structure, such as lytM, encoding a
major autolysin, as well as ssaA and isaA, which encode proteins
potentially involved in peptidoglycan hydrolysis (43). The genes
encoding these proteins were all expressed to a higher extent by
S. aureus during bone infection.
A total of 42 genes exhibited lower expression levels in S. aureus
during CH than during AC infection. These included genes en-
coding stress-related proteins (ahpF and katA), most probably
reflecting the shift from a highly oxidative/nitrosative environ-
ment imposed by the inflammatory response during the AC phase
of infection to a less harsh environment dominated mainly by
tissue repair processes during the CH phase of infection. Other
genes expressed by S. aureus to a significantly lower extent during
the CH versus AC phase of osteomyelitis comprised genes encod-
ing proteins involved inDNA synthesis and cell division (cvfA, atl,
lytM, and pyrR) or amino acid metabolism (dhoM, gltA, glnA,
thrBC, and ald2). The lower expression of these genes suggests a
drop in the bacterial multiplication rate and amino acid metabo-
lism during the CH phase of infection.
Small regulatory RNAs (sRNAs) represent an additional level
of posttranscriptional gene regulation that allows the pathogen to
adapt to its metabolic needs during infection and to express viru-
lence genes (44). They can be encoded as part of the mRNA that
they regulate (cis-acting RNAs), such as riboswitches or 5= un-
translated regions (UTRs), or as independent transcripts (trans-
acting RNAs) (45). Most sRNAs exert their action either by base-
pairingwith theirmRNA target,modulating its translation and/or
stability, or by binding to proteins, antagonizing their function
(45). In recent years, a number of sRNAs have been identified in
S. aureus (28); however, a specific biological role for most of them
has yet to be assigned. Whereas sRNAs with housekeeping func-
tions, including the 4.5s RNAencoded by the ffs gene, theRNase P,
and SsrA RNA, were highly expressed by S. aureus under all three
conditions, other sRNAs were more highly expressed by S. aureus
during in vivo infection than during in vitro growth. As examples,
rsaC, the function of whose product is still unclear, the T box
involved in the regulation of metB encoding cystathionine
-synthase involved in the synthesis of methionine, and the T box
regulating thrS, which encodes threonyl-tRNA synthetase, a key
enzyme of protein biosynthesis which charges tRNA molecules
with threonine, were among the sRNAs most highly expressed by
S. aureus during the AC phase of infection. The sRNAs ex-
pressed by S. aureus during infection may provide good thera-
peutic targets. In fact, inhibitors of threonyl-tRNA synthetase,
regulated by the T box/thrs, are currently being investigated as
potential therapeutic agents (46). Two S-box riboswitches, metK
(encoding S-adenosylmethionine synthase) andmetN2 (encoding
methionine import ATP-binding protein, which regulates
methionine transport), were among the most highly expressed
sRNAs by S. aureus during the CH phase of infection.
S-Adenosylmethionine serves as amethyl group donor in a variety
of cellular processes and is the precursor molecule in polyamine
synthesis, and its expression is induced in response to starvation
for methionine (47). The S box has been reported to play an im-
portant role in the pathogenicity of S. aureus and consequently has
been proposed as a potential target for new anti-infectives (48).
In summary, this is the first study reporting the transcriptional
response at a whole-genome level of S. aureus during acute and
chronic phases of experimental osteomyelitis. Our results indicate
that during the acute phase of infection, S. aureus experienced
massive transcriptional remodeling to adapt to the nutrient avail-
ability in the tissue and to the biological pressure imposed by the
host immune system. During the chronic phase, S. aureus
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switched its transcriptional response from a proliferative mode to
a survival mode that enabled persistence. In this regard, chronic
and antibiotic refractory staphylococcal infections have been
linked to the emergence of a subpopulation of S. aureus with a
slow-growing small-colony-variant (SCV) phenotype (49, 50).
SCVs can be regarded as a bacterial strategy for survival and per-
sistence in a harsh environment (49, 50). The transcriptional re-
sponse of S. aureus during the chronic phase of osteomyelitis de-
scribed in our study parallels many features of SCVs. Thus, the
global transcriptional profile obtained in this study may be the
sum of independent responses of different S. aureus subpopula-
tions present in the infected bone. It would be therefore of great
interest to find a way to discriminate the transcriptional response
of the SCVs from that of the original parental bacterial population
during in vivo infection.
MATERIALS AND METHODS
Ethics statement. Ethical approval for the experiments, including those
using human samples, was obtained from the Ethy Kommission der Är-
ztekammer Westfalen-Lippe und der Medizinische Fakultät der West-
fälischen Wilhelms-Universität (permit 2014-376-f-S).
Animal experiments were performed in strict accordance with the
German regulations of the Society for Laboratory Animal Science (GV-
SOLAS) and the European Health Law of the Federation of Laboratory
Animal Science Associations (FELASA). All experiments were approved
by the ethical board Niedersächsisches Landesamt für Verbraucherschutz
und Lebensmittelsicherheit, Oldenburg, Germany (permit 33.9-42502-
04-10/0296).
Bacteria. S. aureus strain 6850, originally isolated from a patient with
a skin abscess that progressed to staphylococcal bacteremia, hematoge-
nous osteomyelitis, septic arthritis, and multiple systemic abscesses, was
used in this study (8, 9). Bacteria were cultivated in brain heart infusion
(BHI) medium (Roth, Karlsruhe, Germany) under microaerobic condi-
tions using a 5:1 flask volume ratio and incubated on a shaker at 37°C and
125 rpm. As a reference for the downstream RNA-Seq analyses, S. aureus
was harvested during the exponential (EX) (optical density at 600 nm
[OD600] 0.4) growth phase.
Mice and infectionmodel. Pathogen-free C57BL/6 10-week-oldmice
were obtained from Harlan-Winkelmann (Borchen, Germany) and in-
fected with 106 CFU of S. aureus in 150 l of phosphate-buffered saline
(PBS) via a lateral tail vein as previously described (6). Three independent
sets of 8 to 10mice were sacrificed by CO2 asphyxiation at day 7 (AC) and
day 28 (CH) of infection; the tibiae from each animal were removed by
dissection, and the RNA was stabilized by incubation in 2 ml of RNAlater
solution (Ambion) overnight at 4°C.
Bacterial extraction from infected bones using antibody-bound
magnetic beads. RNA-stabilized samples were homogenized in 2 ml of
sterile PBS supplemented with 1% -mercaptoethanol (Sigma), and tis-
sue debris was removed by centrifugation at 200  g for 5 min at 4°C.
Magnetic beads bound to anti-S. aureus IgG antibodies were employed to
extract S. aureus from the bone homogenates prior to RNA extraction.
Purified rabbit anti-S. aureus IgG antibodies were coupled to sheep anti-
rabbit IgG conjugatedmagnetic Dynabeads (1g/107 beads;M280; Invit-
rogen), washed with sterile PBS supplemented with 0.1% bovine serum
albumin (BSA), and resuspended in 1 ml of sterile PBS–0.1% BSA. A
volume of 50 l (~107 beads) was added to the bone homogenates, and
the mixture was incubated with gentle agitation at room temperature for
30 min. The beads were subsequently pelleted in a magnetic rack (NEB),
washed with 1 ml of sterile PBS–0.1% BSA, treated with 100 l of lyso-
staphin (5g/ml) (Sigma) for 10min at room temperature, and subjected
to RNA extraction. In vitro-grown S. aureus was also subjected to
antibody–magnetic-bead separation to minimize the effects of sample
preparation and processing on downstream comparative RNA-Seq data
analyses.
Total RNA extraction, purification, andmRNA enrichment. For ex-
traction of total RNA, S. aureus cells isolated from in vitro cultures and
infected bones were resuspended in 1 ml of cold RLT (guanidine thiocy-
anate) buffer (Qiagen) supplemented with 1% -mercaptoethanol
(Sigma) and transferred to lysingmatrix B tubes (MPBiomedicals) on ice.
Samples were disrupted using the FastPrep-24 instrument (MP Biomedi-
cals) at an intensity of 5.5 for 40 s. Samples were returned to ice for 4 min,
disrupted further using the same settings, and then centrifuged at 13,500
 g for 10 min at 4°C. The supernatant was subsequently transferred to
1.5-mlRNase-free Biopur centrifuge tubes (Eppendorf), and theRNAwas
extracted using the RNeasy minikit according to the manufacturer’s in-
structions, including optional DNase treatment on the column (Qiagen).
RNA was eluted with nuclease-free water (Ambion) and concentrated by
ethanol precipitation using standard procedures.
To remove any possibly contaminating DNA, a further DNase treat-
ment step was performed on all samples using the Turbo DNA-free kit
(Invitrogen), and the samples were concentrated by ethanol precipitation.
The mRNA was subsequently enriched from the samples using Termina-
tor 5=-phosphate-dependent exonuclease (Epicentre) according to the
manufacturer’s instructions. Samples were further concentrated by etha-
nol precipitation and re-eluted in nuclease-free water (Ambion). RNA
integrity and quantity were measured using the Agilent 2100 Bioanalyzer
(Agilent Technologies) and NanoDrop 1000 spectrophotometer
(Thermo Scientific).
For extraction of total RNA from clinical specimens, bones were ho-
mogenized in 1 ml of lysis buffer (RNAPro solution; MP Biomedicals)
supplemented with 1% -mercaptoethanol and further disrupted using
lysingmatrix B beads (MPBiomedicals) in a FastPrep-24 instrument. Cell
lysates were then centrifuged at 13,500 g for 2min at 4°C, and total RNA
was extracted from all samples using the RNeasy minikit (Qiagen). To
eliminate DNA contamination, each RNA sample was treated with 2.5 l
of DNase I (Qiagen) and incubated for 30 min at room temperature.
Following this, RNA samples were cleaned up and concentrated using the
RNeasy MinElute cleanup kit (Qiagen).
Illumina library generation and sequencing. Libraries were gener-
ated using the ScriptSeq v2 RNA-Seq library preparation kit (Epicentre)
and purified using the Minelute PCR purification kit (Qiagen) according
to the manufacturer’s instructions. Libraries were sequenced on the Illu-
mina HiSeq 2500 platform using the TruSeq S.R. cluster kit, v3-cBot-HS
(Illumina). Three libraries weremultiplexed per lane (12 pM/library) and
sequenced to 58 cycles in one direction. Each library produced between 53
and 105 million reads of 50 nucleotides (nt).
RNA-Seq data processing. Sequence reads were preprocessed for
quality and trimmed using a combination of in-house Ruby scripts and
open-source tools (http://wiki.bioinformatics.ucdavis.edu/index.php
/Trim.pl and http://www.mothur.org/). Readsmatching rRNA sequences
were identified and filtered by BLAST searching against the ribosomal
genes annotated in the genome of the S. aureus strain SAU6850 (9).
Reads were collapsed into unique representatives, associated to their copy
numbers, andmapped to the S. aureus strain 6850 genome sequence using
BLAST (51). In addition, the small fraction of noncoding mRNA reads
(from 0.01 to 7.3% of the total generated reads per library) was further
BLAST searched against the BSRD database (http://kwanlab.
bio.cuhk.edu.hk/BSRD), where sequence matches of28 nt with98%
sequence homology and an E value of 0.001 were considered. Raw
mapped read counts were then either normalized as the numbers of reads
per kb of transcript per million reads mapped (RPKM) (52) or randomly
resampled to the smallest library size of 26,251 reads, taking the average
from 999 resampling events (using an in-house Perl script).
qRT-PCR in clinical samples.Total RNAwas isolated from S. aureus-
infected clinical specimens, and the expression of seven genes (adi, arcC,
clfA, dnaK, RSAU_000587, ldh1, and sspB), as well as two housekeeping
genes, gyrB and tpiA, was quantified by qRT-PCR. RNA samples were
reverse transcribed and amplified with a SensiFAST SYBR No-ROX one-
step kit using the LightCycler 480 real-time PCR system. Thermal cycling
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conditions consisted of reverse transcription for 15 min at 45°C and acti-
vation of polymerase for 5 min at 95°C, followed by 40 cycles of 20 s at
95°C, 20 s at 58°C, and 20 s at 72°C, which correspond to denaturation,
annealing, and extension, respectively. Primer sequences (see Table S8 in
the supplemental material) were designed for each gene as described
above. The S. aureus strain isolated from each human sample (n 5) (see
Table S7 in the supplemental material) and grown to an OD600 of 0.4 to
0.5 (EX growth) was used as a reference for quantitative RT-PCR analyses.
Values were normalized against the values for the housekeeping genes
gyrB and tpiA, and the relative copy numbers for each genewere estimated
using the Pfaffl equation (53). Values were expressed as the change (fold)
between the expression of the specific gene in human tissue and the ex-
pression in in vitro exponential-growth-phase samples.
Statistical analysis. Statistical analyses were carried out using both
PRIMER (v.6.1.6, PRIMER-E; PlymouthMarine Laboratory) and the free
software R package for statistical computing and graphics (http://www.r-
project.org). To assess the global similarity between replicates within each
growth phase (EX, AC, and CH), a sample-similarity matrix was gener-
ated using the Bray-Curtis coefficient, and the transcriptome profiles were
compared by both principal coordinates analysis (PCoA) and group-
average agglomerative hierarchical clustering. A permutational multivar-
iate analysis of variance (PERMANOVA) (54) was used to determine the
statistical significance of the global transcriptional profile of independent
conditions (EX, AC, and CH). For the one-way PERMANOVA, where
condition was the main factor, the resemblance matrix was derived fol-
lowing the Bray-Curtis algorithm using type III (partial) sums of squares
with a fixed effects sum to zero for mixed terms. Exact P values were
generated using unrestricted permutation of raw data. Pseudo-F statistic
and generated P values were reported for each pair of conditions where
differences in gene expression were observed. Further pairwise tests were
also conducted using PERMANOVA.Monte Carlo tests were undertaken
in the pairwise test function in PERMANOVA if low permutations were
obtained. The Monte Carlo (P) value is better suited and more reliable
when there are not enough possible permutations. The conditions were
considered significantly different if the P value fell below 0.05.
To assess differential gene expression between conditions, univariate
algorithms were applied to the rerandomized data after genes for which
transcripts levels were below 0.05% (14 copies per 26,251 reads) had
been filtered out. Considering that there is no current consensus onwhich
algorithm to use for determination of differential expression in RNA-Seq
data, three robust algorithms—DESeq and EdgeR, assuming an NB dis-
tribution, and SAMseq, assuming a distribution-free condition (all in
Bioconductor, R package)—were applied, and a gene was considered sig-
nificantly different in expression between a pair of conditions if the
P value fell to 0.05 in any 2 of the 3 algorithm methods used (EdgeR,
DESeq, and SAMseq). All P values were corrected for multiple testing
using default parameters.
RNA sequence accession number. The RNA sequencing reads have
been deposited at the European Nucleotide Archive under the accession
number PRJEB6003 (http://www.ebi.ac.uk/ena/data/view/PRJEB6003).
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